Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7779]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Phase III trial did not show superiority of eribulin compared with capecitabine...
Dr Peter Kaufman - Norris Cotton Cancer Center, New Hampshire, USA
Phase III trial did not show superiority of eribulin compared with capecitabine in metastatic breast cancer ( Dr Peter Kaufman - Norris Cotton Cancer Center, New Hampshire, USA )
12 Dec 2012
Potential targets and complications of apoptosis and necrosis
Dr Doug Green – St Jude Children’s Research Hospital, Memphis, USA
Potential targets and complications of apoptosis and necrosis ( Dr Doug Green – St Jude Children’s Research Hospital, Memphis, USA )
7 Dec 2012
Prognostic signatures in colon cancer
Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain
Prognostic signatures in colon cancer ( Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain )
7 Dec 2012
Targeting the proteasome mechanism
Dr Stig Linder – Karolinska Institute, Stockholm, Sweden
Targeting the proteasome mechanism ( Dr Stig Linder – Karolinska Institute, Stockholm, Sweden )
7 Dec 2012
Effect of hypoxia on cancer progression and adaptive response
Dr Greg Semenza – John Hopkins, Baltimore, USA
Effect of hypoxia on cancer progression and adaptive response ( Dr Greg Semenza – John Hopkins, Baltimore, USA )
7 Dec 2012
New agents and mTOR inhibitors
Dr David Sabatini – Whitehead Institute, Boston, USA
New agents and mTOR inhibitors ( Dr David Sabatini – Whitehead Institute, Boston, USA )
7 Dec 2012
Oncogenes and genetic aberration
Dr Tak Mak – Cambell Institute, Ontario, Canada
Oncogenes and genetic aberration ( Dr Tak Mak – Cambell Institute, Ontario, Canada )
7 Dec 2012
HDAC inhibitors sensitise triple-negative breast cancer cells to PARP...
Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA
HDAC inhibitors sensitise triple-negative breast cancer cells to PARP inhibition and cisplatin treatment ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )
6 Dec 2012
Transcriptional regulation of endothelial cell differentiation
Dr Elisabetta Dejana – IFOM – University of Milan, Italy
Transcriptional regulation of endothelial cell differentiation ( Dr Elisabetta Dejana – IFOM – University of Milan, Italy )
22 Nov 2012
Novel molecular insights on vertebrate genome stability maintenance
Dr Vincenzo Costanzo – IFOM-IEO, Milan, Italy
Novel molecular insights on vertebrate genome stability maintenance ( Dr Vincenzo Costanzo – IFOM-IEO, Milan, Italy )
21 Nov 2012
Stem cell generation of tumors and tissue physiology
Dr Colin Jamora – IFOM – Institute for Stem Cell Biology and Regenerative...
Stem cell generation of tumors and tissue physiology ( Dr Colin Jamora – IFOM – Institute for Stem Cell Biology and Regenerative Medicine, India )
21 Nov 2012
Regulating the p53 pathway
Dr David Lane – Agency for Science, Technology and Research, Singapore
Regulating the p53 pathway ( Dr David Lane – Agency for Science, Technology and Research, Singapore )
21 Nov 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation